Profil
Thomas E.
Jenkins is the founder of Elysium Therapeutics, Inc., founded in 2013, where the title held is Chief Scientific Officer.
Former job includes Chief Scientific Officer & Vice President-Research at Signature Therapeutics, Inc. Education history includes a doctorate from Stanford University and an undergraduate degree from the University of Akron.
Aktive Positionen von Thomas Jenkins
| Unternehmen | Position | Beginn |
|---|---|---|
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Gründer | 01.01.2013 |
Ehemalige bekannte Positionen von Thomas Jenkins
| Unternehmen | Position | Ende |
|---|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Thomas Jenkins
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Signature Therapeutics, Inc.
Signature Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Akron
University of Akron Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elysium Therapeutics, Inc.
Elysium Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development in biotechnology | Health Technology |
















